Lourdes Ylagan, MD, FIAC
Lourdes Ylagan, MD, FIAC
My area of interest is in the detection of malignant cells in all body sites using light microscopy, immunohistochemistry and biomarker assays. Through collaborations with clinical teams interested in biomarker discovery, analysis of such markers in tissues and cells, particularly when it relates to patient treatment and clinical outcomes, is what our lab is most passionate about.
I am also passionate about riding my bike and getting others to do the same. I learned as an adult having grown from the Philippines where bicycle riding was not permitted among girls. Through the tutelage of an AML cancer survivor who coached me on my first fundraising ride with the Leukemia and Lymphoma Society’s Team-n-training, I have since fundraised and rode with LLS, MS 150, Tour de Cure, and of course, the Ride for Roswell. I came to Roswell because this place gives me a great sense of purpose and pride.
- Cote GA, Hovis CE, Kohlmeier C, Ammar T, Al-Lehibi A, Azar RR, Edmundowicz SA, Mullady DK, Krigman H, Ylagan L, Hull M, Early DS. Training in EUS-guided fine needle aspiration: Safety and diagnostic yield of attending supervised, trainee-directed FNA from the onset of training. Diagnostic and therapeutic endoscopy 2011; 2011:378540
- Vidal M, Salavaggione L, Ylagan L, Wilkins M, Watson M, Weilbaecher K, Cagan R. A role for the epithelial microenvironment at tumor boundaries: Evidence from drosophila and human squamous cell carcinomas. American journal of pathology 2010; 1766:3007-3014
- Aft R, Ellis M, Weiss P, Eberlein T, Ma C, Fracasso PM, Zoberi I, Taylor M, Gillanders W, Pluard T, Mortimer J, Ali A, Dietz J, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, Zhai J, Kuo S, Shannon W, Diemer K, Herrmann V, Weilbaecher K. Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: An open label, randomised, phase 2 trial.Lancet oncology 2010; 115:421-428
- Traugott AL, Ylagan L, Davila R, Hussain H, Quayle F, Fialkowski E, Cohen M, Trinkaus K, Dehdashti F, Moley JF. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World journal of surgery 2010; 346:1247-1253
- Sanati S, Huettner P, Ylagan LR. Role of ProExC: A novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. International journal of gynecological pathology 2010; 291:79-87